1-3 of 3
Steve Kornblau, MD
Close
Sort by
Journal Articles

Intensification of Hyper-CVAD with L-Asparaginase, Vincristine, and Dexamethasone ("Augmented Hyper-CVAD") Has Activity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL).

Stefan Faderl, MD, Deborah A. Thomas, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Miloslav Beran, MD PhD, Michael Rytting, MD, Charles A. Koller, MD, Srdan Verstovsek, MD PhD, Gautam Borthakur, MD, Michael Andreeff, MD PhD, Steve Kornblau, MD, Susan O’Brien, MD, Khanh Vu, MD, Monica Kwari, RN, Jennie Bretz, RN, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2007) 110 (11): 4324.
https://doi.org/10.1182/blood.V110.11.4324.4324
Published: 2007
Journal Articles

Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia (ALL): The MDACC Experience with Intensified L-Asparaginase and Vincristine in Adult ALL Salvage.

Stefan Faderl, MD, Deborah A. Thomas, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Miloslav Beran, MD, PhD, Michael Rytting, MD, Charles A. Koller, MD, Srdan Verstovsek, MD, PhD, Gautam Borthakur, MD, Michael Andreeff, MD, PhD, Steve Kornblau, MD, Khanh Vu, MD, Rita Jarmon, R.N., Hagop M. Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 1840.
https://doi.org/10.1182/blood.V106.11.1840.1840
Published: 2005
Journal Articles

Phase I Study of Clofarabine Plus Idarubicin and Clofarabine Plus Idarubicin Plus Cytarabine (ARA-C) in Patients (PTS) with Relapsed and Primary Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myeloid Blast Phase of Chronic Myeloid Leukemia (CML).

Stefan Faderl, MD, Alessandra Ferrajolil, MD, William Wierda, MD PhD, Srdan Verstovsek, MD, PhD, Farhad Ravandi-Kashani, MD, Guillermo Garcia-Manero, MD, Elihu Estey, MD, Deborah A. Thomas, MD, Steve Kornblau, MD, Monica Kwari, RN, Varsha Gandhi, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2004) 104 (11): 1809.
https://doi.org/10.1182/blood.V104.11.1809.1809
Published: 2004